Perspectivas del mercado y visión del analista:
La EPOC es una afección a largo plazo que causa inflamación pulmonar, daña el tejido pulmonar y provoca el estrechamiento de la vías respiratorias, dificultando la respiración. El tamaño del mercado de dispositivos para la EPOC se está expandiendo con el aumento de las actividades de I+D para desarrollar inhaladores inteligentes para el tratamiento de la EPOC, el creciente número de casos de EPOC y el creciente apoyo gubernamental para el tratamiento de la EPOC. Además, la disponibilidad de productos avanzados de los actores del mercado está impulsando aún más el crecimiento del mercado. Por ejemplo, en junio de 2021, Glenmark Pharma lanzó el inhalador de polvo seco de bromuro de tiotropio, utilizado para tratar la EPOC en el Reino Unido.
Impulsores de crecimiento y desafíos:
La EPOC es una enfermedad pulmonar crónica que causa inflamación pulmonar, lo que provoca obstrucción del flujo de aire desde los pulmones. Los síntomas de la EPOC incluyen dificultad para respirar, producción de moco (esputo), tos y sibilancias. Por lo general, es causada por una exposición prolongada a gases irritantes o partículas, generalmente provenientes del humo del cigarrillo. Las personas que padecen EPOC tienen un mayor riesgo de desarrollar cáncer de pulmón, enfermedades cardíacas y una variedad de otras afecciones. Según la Asociación Estadounidense del Pulmón, la EPOC es la principal causa de muerte en los EE. UU., y más de 12 millones de estadounidenses fueron diagnosticados con estas enfermedades en 2022. Según la misma fuente, ~8,5 millones de adultos en todo el mundo fueron diagnosticados con EPOC durante 2019-2020. . Según la Organización Mundial de la Salud (OMS), en 2021, la EPOC fue la tercera causa importante de muerte en todo el mundo. La alta tasa de mortalidad de la EPOC se debe a exacerbaciones agudas, que provocan insuficiencia de los músculos respiratorios de los pacientes, lo que resulta en la pérdida de la capacidad del paciente para respirar de forma independiente; como resultado, los pacientes mueren por infección sistémica y asfixia. Además, según el informe sobre la carga de la enfermedad pulmonar obstructiva (BOLD), en 2020, se prevé que la mortalidad debida a la EPOC aumente en todo el mundo durante los próximos 40 años, y se espera que alcance ~5,4 millones de muertes anuales para 2060. La creciente prevalencia de La EPOC a nivel mundial está impulsando el crecimiento del mercado de dispositivos para la EPOC.
Perspectivas estratégicas
Segmentación y alcance del informe:
El mercado de dispositivos para la EPOC está segmentado según el tipo de producto, el grupo de edad, el canal de distribución y la geografía. El mercado de dispositivos para la EPOC, por tipo, se segmenta en inhalador y nebulizador. El mercado de dispositivos para la EPOC, por grupo de edad, se segmenta en 20 a 40 años, 41 a 65 años, 66 a 80 años y 85+ años. El mercado de dispositivos para la EPOC, por canal de distribución, se segmenta en farmacias hospitalarias, farmacias minoristas y farmacias online. Según la geografía, el mercado de dispositivos para la EPOC se clasifica en América del Norte (EE. UU., Canadá y México), Europa (Reino Unido, Alemania, Francia, Italia, España y resto de Europa), Asia Pacífico (China, Australia, Japón, India). , Corea del Sur y el resto de Asia Pacífico), Medio Oriente y África (EAU, Arabia Saudita, Sudáfrica y el resto de Medio Oriente y África) y América del Sur y Central (Brasil, Argentina y el resto de América del Sur y Central). ).
Análisis segmentario:
El mercado de dispositivos para la EPOC, por tipo de producto, se divide en inhaladores y nebulizadores. En 2022, el segmento de inhaladores tuvo una mayor participación de mercado y se espera que registre una CAGR más alta durante el período de pronóstico. Los inhaladores de dosis medidas (MDI) y los inhaladores de polvo seco (DPI) son dos tipos principales de inhaladores que se utilizan para tratar la EPOC. A diferencia de otros inhaladores que proporcionan una dosis de medicamento, estos inhaladores contienen el medicamento como un polvo seco. El paciente necesita respirar rápida y profundamente para que el medicamento llegue a los pulmones. Los inhaladores de polvo seco son alternativas clínicamente apropiadas y rentables. Los inhaladores de dosis medidas (MDI) son sistemas inhaladores presurizados portátiles que proporcionan directamente dosis pequeñas y precisas de medicamento a las vías respiratorias del paciente. Los dispositivos MDI incluyen una válvula y un actuador que facilita la administración constante de una dosis precisa de medicamento al paciente en partículas de una distribución de tamaño exacta administradas a través de un propulsor. Estos inhaladores requieren gas propulsor con presiones de vapor que puedan licuarse a temperaturas entre 40 y 70 psi dentro del recipiente. Los combustibles utilizados en estos MDI para inhalación de medicamentos deben estar certificados por la Administración de Alimentos y Medicamentos. Debería implicar el grado de inhalación actual de Buenas Prácticas de Fabricación (cGMP) con altos niveles de pureza.
Mercado de dispositivos para la EPOC, por tipo de producto: 2022 y 2030
Análisis regional:
Según la geografía, el mercado de dispositivos para la EPOC se clasifica en América del Norte, Europa, Asia Pacífico, Medio Oriente y África, y Sur y África. Centroamérica. América del Norte es el mayor contribuyente al crecimiento del mercado mundial de dispositivos para la EPOC. Además, se prevé que Asia Pacífico registre la CAGR más alta en el mercado mundial de dispositivos para la EPOC durante el período de pronóstico. Es probable que el crecimiento futuro de este mercado se atribuya a la creciente prevalencia de trastornos respiratorios. Además, la enfermedad pulmonar obstructiva crónica (EPOC) es una carga de salud importante en los EE. UU. La EPOC es causada por la obstrucción del flujo de aire desde los pulmones, lo que puede provocar una enfermedad pulmonar inflamatoria crónica. Fumar es una de las principales causas de EPOC en los EE. UU. La creciente preferencia por fumar en EE.UU. está impulsando el crecimiento del mercado de dispositivos para la EPOC. Según los Centros para el Control y la Prevención de Enfermedades (CDC), ~14,8 millones de adultos en los EE. UU. padecen EPOC.
Además, según la Administración para la Vida Comunitaria, las personas de 65 años o más en los EE. UU. representaban 54,1 millones , que representa el 16% de la población total, y se espera que alcance el 21,6% en 2040. Los adultos mayores son extremadamente susceptibles a las enfermedades respiratorias crónicas. Por lo tanto, también se espera que un aumento de la población de mayor edad impulse la demanda de inhaladores respiratorios durante el período previsto. Además, se prevé que las políticas de reembolso favorables creen varias oportunidades para el crecimiento del mercado de dispositivos para la EPOC en la región.
Desarrollos de la industria y oportunidades futuras:
A continuación se enumeran varios planes de los actores clave que operan en el mercado de dispositivos para la EPOC:
En abril de 2022, GlaxoSmithKline Pharmaceuticals Limited lanzó Trelegy Ellipta (furoato de fluticasona/umeclidinio/vilanterol) en la India. Es la primera terapia triple con un solo inhalador (SITT) para pacientes con EPOC en un régimen de una vez al día. El producto también fue aprobado por el Contralor General de Medicamentos de la India (DCGI) para el consumo de Trelegy Ellipta como tratamiento de mantenimiento para prevenir y aliviar los síntomas relacionados con la EPOC en pacientes de 18 años o más. Panorama competitivo y empresas clave:
Algunas de los actores destacados que operan en el mercado de dispositivos para la EPOC son AstraZeneca PLC, Beximco Pharmaceuticals Ltd, Getinge AB, Boehringer Ingelheim, GSK Plc, Medtronic PLC, Nephron Pharmaceuticals, Novartis AG, Sunovion Pharmaceuticals Inc y Teva Pharmaceuticals. Estas empresas se centran en expansiones geográficas y lanzamientos de nuevos productos para satisfacer la creciente demanda de los consumidores en todo el mundo y aumentar su gama de productos en carteras especializadas. Su presencia global les permite atender a una gran base de clientes, lo que posteriormente facilita la expansión del mercado.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The COPD devices market majorly consists of the players such AstraZeneca PLC, Beximco Pharmaceuticals Ltd, Getinge AB, Boehringer Ingelheim, GSK Plc, Medtronic PLC, Nephron Pharmaceuticals, Novartis AG, Sunovion Pharmaceuticals Inc, and Teva Pharmaceuticals
Chronic obstructive pulmonary disease, or COPD, refers to a group of diseases that cause airflow blockage and breathing-related problems. It includes emphysema and chronic bronchitis. In people with COPD, the lungs can get damaged or clogged with phlegm. Symptoms include cough, sometimes with phlegm, difficulty breathing, wheezing and tiredness. Smoking and air pollution are the most common causes of COPD. People with COPD are at higher risk of other health problems.According to Centers for Diseases Control and Prevention (CDC), COPD makes breathing difficult for the 16 million Americans who have this disease. everal inhalation device types are available, including metered-dose inhalers (MDIs), dry-powder inhalers (DPIs), soft mist inhalers (SMIs), and small volume nebulizers (SVNs). Each of these devices has unique attributes to consider when selecting treatment for a specific patient.
The increasing cases of COPD, and strategic initiatives in COPD devices bolster the COPD devices market size. However, the high cost associated with COPD devices hinders the COPD devices market growth.
Based on geography, the COPD devices market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). North America is the largest contributor to the growth of the global COPD devices market. Asia Pacific is expected to register the highest CAGR in the COPD devices market during 2022–2030.
The COPD devices market, by product type, is bifurcated into inhaler and nebulizer. In 2022, the inhaler segment held a larger market share, and it is expected to record a higher CAGR during the forecast period. The COPD devices market, by distribution channel, is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. In 2022, the retail pharmacies segment held the largest market share; moreover, the same segment is expected to record the highest CAGR during the forecast period. Online pharmacies are the fastest-growing distribution channel of the COPD devices market.
The List of Companies - COPD Devices Market
- AstraZeneca PLC
- Beximco Pharmaceuticals Ltd
- Getinge AB
- Boehringer Ingelheim
- GSK Plc
- Medtronic PLC
- Nephron Pharmaceuticals
- Novartis AG
- Sunovion Pharmaceuticals Inc
- Teva Pharmaceuticals
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Jan 2024
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Jan 2024
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2024
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2024
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2024
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2024
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2024
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Jan 2024
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)